Stephen Rocamboli

Insider Reports History

Location
C/Oparmount Capital, 787 Seventh Ave 48 Th Fl, New York, NY
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Rocamboli:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Director Common Stock 69.3K $55.4K $0.80 May 29, 2025 Direct
Esperion Therapeutics, Inc. Director Stock Option (right to buy) 44K $52.7K $1.62 May 29, 2025 Direct
TFF Pharmaceuticals, Inc. Director Common Stock 39.2K $15.3K $0.39 Jul 3, 2024 Direct
TFF Pharmaceuticals, Inc. Director Restricted stock units 4.67K $1.83K $0.39 Apr 18, 2024 Direct
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 3.17K Jul 3, 2024 Direct

Insider Reports Filed by Stephen Rocamboli

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. May 29, 2025 2 $0 4 Jun 2, 2025 Director
TFFP TFF Pharmaceuticals, Inc. Jul 3, 2024 2 $0 4 Jul 8, 2024 Director
ESPR Esperion Therapeutics, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
TFFP TFF Pharmaceuticals, Inc. Apr 18, 2024 1 $0 4 Apr 22, 2024 Director
TFFP TFF Pharmaceuticals, Inc. Dec 1, 2023 1 $0 4 Dec 4, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Aug 15, 2023 1 $5K 4 Aug 15, 2023 Director
ESPR Esperion Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
ESPR Esperion Therapeutics, Inc. May 10, 2023 1 $12.1K 4 May 11, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Mar 10, 2023 1 $10.4K 4 Mar 13, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Dec 29, 2022 1 $0 4 Dec 30, 2022 Director
ESPR Esperion Therapeutics, Inc. May 26, 2022 2 $0 4 May 27, 2022 Director
TFFP TFF Pharmaceuticals, Inc. May 16, 2022 1 $13.6K 4 May 17, 2022 Director
ESPR Esperion Therapeutics, Inc. Apr 28, 2022 0 $0 3 Apr 28, 2022 Director